- Home
- WNW vs CDIO Comparison
WNW vs CDIO Comparison
Compare WNW & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNW
- CDIO
- Stock Information
- Founded
- WNW 2015
- CDIO 2017
- Country
- WNW China
- CDIO United States
- Employees
- WNW N/A
- CDIO N/A
- Industry
- WNW Catalog/Specialty Distribution
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- WNW Consumer Discretionary
- CDIO Health Care
- Exchange
- WNW Nasdaq
- CDIO Nasdaq
- Market Cap
- WNW 5.4M
- CDIO 6.4M
- IPO Year
- WNW 2020
- CDIO N/A
- Fundamental
- Price
- WNW N/A
- CDIO N/A
- Analyst Decision
- WNW
- CDIO
- Analyst Count
- WNW 0
- CDIO 0
- Target Price
- WNW N/A
- CDIO N/A
- AVG Volume (30 Days)
- WNW 47.6K
- CDIO 40.0K
- Earning Date
- WNW 11-14-2025
- CDIO 11-12-2025
- Dividend Yield
- WNW N/A
- CDIO N/A
- EPS Growth
- WNW N/A
- CDIO N/A
- EPS
- WNW 9.06
- CDIO N/A
- Revenue
- WNW $158,485.00
- CDIO $19,507.00
- Revenue This Year
- WNW N/A
- CDIO $1,434.82
- Revenue Next Year
- WNW N/A
- CDIO $4,661.91
- P/E Ratio
- WNW $0.23
- CDIO N/A
- Revenue Growth
- WNW N/A
- CDIO N/A
- 52 Week Low
- WNW $0.95
- CDIO $3.22
- 52 Week High
- WNW $70.00
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- WNW N/A
- CDIO 58.63
- Support Level
- WNW N/A
- CDIO $4.16
- Resistance Level
- WNW N/A
- CDIO $4.63
- Average True Range (ATR)
- WNW 0.00
- CDIO 0.33
- MACD
- WNW 0.00
- CDIO 0.03
- Stochastic Oscillator
- WNW 0.00
- CDIO 56.28
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.